AdaptHealth Corp. (AHCO) FY2025 10-K Annual Report
AdaptHealth Corp. (AHCO) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 24, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
AdaptHealth Corp. FY2025 10-K Analysis
Business Overview
- • Core business: Patient-centered healthcare-at-home solutions, including home medical equipment, medical supplies, and related services across four segments (Sleep, Respiratory, Diabetes, Wellness)
- • Newly emphasized: Deployment of artificial intelligence (AI), including generative AI, for improving patient and operational workflows with associated regulatory risks highlighted
- • Strategic shift: Increased focus on advanced technology platform integration and AI to enhance efficiency, compliance, and competitive positioning versus more manual competitors
- • Notable quantitative metric: Serviced approximately 4.3 million patients annually through 640 locations in 48 states; approximately 10,900 employees as of December 31, 2025
- • Distinctive fact: Outsourcing of about 4,400 full-time equivalent personnel for billing and administrative functions primarily in India and the Philippines
Management Discussion & Analysis
- • Net revenue $3.24B in 2025, down 0.5% YoY from $3.26B in 2024, driven by $56.9M organic growth offset by $92.4M disposition decline
- • Operating margin 2.8% in 2025 vs 8.1% in 2024; net loss $(70.8M) vs net income $90.4M; goodwill impairment $128M in 2025 vs $13.1M prior year
- • Best performing segment Respiratory Health: revenue up 6.1% ($40M) to $691.2M; worst performing Wellness at Home: revenue down 9.8% ($63.1M) to $583.1M
- • Cost of net revenue increased 2.2% to $2.64B; G&A expenses up 6.4% to $382.3M; depreciation down 9.8% to $40.6M; capital allocation details not provided
- • Forward outlook highlights inflation risks impacting costs and demand; management leveraging purchasing power and technology for efficiencies; goodwill impairment risks remain
Risk Factors
- • Regulatory risk: 2026 CMS Final Rule bundling payment for CGMs and insulin pumps starting January 1, 2028, may disrupt AdaptHealth's product coverage and reimbursement
- • Macroeconomic risk: Inflation and rising interest rates could increase costs and interest expense on variable rate debt, impairing refinancing and cash flow
- • Supply chain risk: Dependence on few suppliers for patient service equipment exposes AdaptHealth to price hikes, tariffs, and supply disruptions impacting revenue
- • Competitive risk: Pharmacy benefit managers CVS Health and Optum, plus tech giants Amazon and Alphabet, entered HME market, threatening AdaptHealth’s referrals and revenue
- • Financial risk: Capitated agreements with managed care payors pose risk if patient care expenses exceed prepaid fixed payments, impacting earnings
AdaptHealth Corp. FY2025 Key Financial MetricsXBRL
Revenue
$3.2B
▼ -0.5% YoY
Net Income
-$71M
▼ -178.3% YoY
Operating Margin
2.8%
▼ -529bp YoY
Net Margin
-2.2%
▼ -495bp YoY
ROE
-4.7%
▼ -1042bp YoY
Total Assets
$4.3B
▼ -3.8% YoY
EPS (Diluted)
$-0.52
▼ -185.2% YoY
Operating Cash Flow
$602M
▲ +11.1% YoY
Source: XBRL data from AdaptHealth Corp. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on AdaptHealth Corp.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.